Blum Holdings, Inc. (BLMH)
OTCMKTS · Delayed Price · Currency is USD
0.5500
-0.0200 (-3.51%)
Jan 14, 2026, 4:00 PM EST
Blum Holdings Market Cap
Blum Holdings has a market cap or net worth of $17.1 million as of January 15, 2026. Its market cap has increased by 213.59% in one year.
Market Cap
17.10M
Enterprise Value
25.75M
Revenue
13.62M
Ranking
n/a
PE Ratio
0.95
Stock Price
$0.55
Market Cap Chart
Since April 20, 2012, Blum Holdings's market cap has decreased from 94.30M to 17.10M, a decrease of -81.87%. That is a compound annual growth rate of -11.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 17.10M | 11.09% |
| Dec 31, 2025 | 15.39M | 254.91% |
| Dec 31, 2024 | 4.34M | -17.71% |
| Dec 29, 2023 | 5.27M | -33.32% |
| Dec 30, 2022 | 7.90M | -93.99% |
| Dec 31, 2021 | 131.51M | 350.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.56M |
| Glass House Brands | 728.02M |
| Elite Pharmaceuticals | 497.45M |
| Northwest Biotherapeutics | 421.34M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.18M |
| CytoDyn | 342.70M |
| Silence Therapeutics | 260.73M |